Terry Bowersock has a BA in Biology-Psychology from Lawrence University in Appleton, WI, a PhD in Comparative and Experimental Medicine from The University of Tennessee – Knoxville, and a DVM degree from The Ohio State University. He was in a private dairy/mixed veterinary medicine clinic for 3 years. After achieving his PhD he taught Bacteriology in the School of Veterinary Medicine at Purdue University, West Lafayette, IN for 7 years. At Purdue Terry became involved in interdepartmental research with the College of Industrial and Physical Pharmacy. This collaboration involved research on mucosal immunity and alternative vaccine delivery for animals. This work resulted in several patents in oral vaccine delivery technologies. Terry has served on the Board of Governors of The American College of Veterinary Microbiologists (ACVM). He has been an active member of the CRS serving as co-chair of the Veterinary Program Committee, member of Board of Scientific Advisors, and is an editor for the Journal of Controlled Release . He was Co-Editor, of a Special Edition of the Journal of Controlled Release, Veterinary Delivery (vaccine section). In 1996 Terry joined Pharmacia Animal Health (Pfizer Animal Health) where he continued his work on vaccine development for animals. He is now primarily involved in evaluation of vaccines for animals, as well as in the evaluation of alternative delivery technologies as an Associate Director of Global Biological Research and Development at Zoetis, Kalamazoo, Michigan, USA.